Breathe BioMedical Inc. (BRTH)

Breathe BioMedical was planning to go public, but the IPO was withdrawn on Oct 28, 2024.

IPO Price Range

$4.00 - $6.00

Shares Offered

2,625,000

Deal Size

$13.13M

Breathe BioMedical Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	-	4.43	2.7	2.52
Research & Development	-	2.09	1.82	1.6
Other Operating Expenses	0	2.65	0.88	0.93
Operating Expenses	-	9.17	5.4	5.05
Operating Income	-11.35	-9.17	-5.4	-5.05
Interest Expense / Income	-	0.02	-0.01	-0.01
Other Expense / Income	-0.81	-0.83	-0.93	-1.07
Pretax Income	-10.54	-8.36	-4.46	-3.97
Net Income	-10.54	-8.36	-4.46	-3.97
Free Cash Flow	-6.98	-5.22	-3.53	-3.5
EBITDA	-	-7.88	-4.21	-
Depreciation & Amortization	-	0.47	0.26	0.22
EBIT	-	-8.35	-4.47	-

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).